188 related articles for article (PubMed ID: 2532535)
1. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
[TBL] [Abstract][Full Text] [Related]
2. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T
Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia.
Sato T; Fuse A; Eguchi M; Hayashi Y; Ryo R; Adachi M; Kishimoto Y; Teramura M; Mizoguchi H; Shima Y
Br J Haematol; 1989 Jun; 72(2):184-90. PubMed ID: 2527057
[TBL] [Abstract][Full Text] [Related]
5. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome.
Hayashi Y; Eguchi M; Sugita K; Nakazawa S; Sato T; Kojima S; Bessho F; Konishi S; Inaba T; Hanada R
Blood; 1988 Jul; 72(1):15-23. PubMed ID: 2968822
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder.
Coulombel L; Derycke M; Villeval JL; Leonard C; Breton-Gorius J; Vial M; Bourgeois P; Tchernia G
Br J Haematol; 1987 May; 66(1):69-76. PubMed ID: 2954579
[TBL] [Abstract][Full Text] [Related]
8. Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis.
Miyauchi J; Ito Y; Kawano T; Tsunematsu Y; Shimizu K
Blood; 1992 Sep; 80(6):1521-7. PubMed ID: 1387814
[TBL] [Abstract][Full Text] [Related]
9. Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocytic markers.
Sartori PC; Darbyshire PJ
Pediatr Hematol Oncol; 1991; 8(2):139-45. PubMed ID: 1830754
[TBL] [Abstract][Full Text] [Related]
10. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
11. Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's syndrome.
Suda J; Eguchi M; Ozawa T; Furukawa T; Hayashi Y; Kojima S; Maeda H; Tadokoro K; Sato Y; Miura Y
Br J Haematol; 1988 Feb; 68(2):181-7. PubMed ID: 2964860
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
13. Transient megakaryoblastic proliferation in a newborn infant with Down's syndrome.
Hayashi Y; Hanada R; Yamamoto K; Ohde S; Niitsu N; Eguchi M; Sugita K; Nakazawa S
Cancer Genet Cytogenet; 1987 Oct; 28(2):373-4. PubMed ID: 2957044
[No Abstract] [Full Text] [Related]
14. Philadelphia chromosome-positive blastic leukaemia: ultrastructural and ultracytochemical evidence of basophil and mast cell differentiation.
Parkin JL; McKenna RW; Brunning RD
Br J Haematol; 1982 Dec; 52(4):663-77. PubMed ID: 6291577
[TBL] [Abstract][Full Text] [Related]
15. Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker.
McElwaine S; Mulligan C; Groet J; Spinelli M; Rinaldi A; Denyer G; Mensah A; Cavani S; Baldo C; Dagna-Bricarelli F; Hann I; Basso G; Cotter FE; Nizetic D
Br J Haematol; 2004 Jun; 125(6):729-42. PubMed ID: 15180862
[TBL] [Abstract][Full Text] [Related]
16. Megakaryoblastic leukemia and Down's syndrome: a review.
Zipursky A; Peeters M; Poon A
Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
[TBL] [Abstract][Full Text] [Related]
17. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.
Kanegane H; Watanabe S; Nomura K; Xu G; Ito E; Miyawaki T
Int J Hematol; 2007 Oct; 86(3):250-2. PubMed ID: 17988992
[TBL] [Abstract][Full Text] [Related]
18. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
19. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome.
Brissette MD; Duval-Arnould BJ; Gordon BG; Cotelingam JD
Am J Hematol; 1994 Dec; 47(4):316-9. PubMed ID: 7977305
[TBL] [Abstract][Full Text] [Related]
20. Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome.
Wilkie AO; Kitchen C; Oakhill A; Howell RT; Berry PJ
J Clin Pathol; 1988 Apr; 41(4):378-80. PubMed ID: 2966817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
